The Taiwan Monthly - Special Edition

11 Apr. 2024

Listed Companies and Initial Public Offerings

Securities Listing Review Committee of the Taiwan Stock Exchange approved the initial listing application on TIB of UNICOCELL BIOMED Co., Ltd.

The 803rd meeting of the Securities Listing Review Committee of the Taiwan Stock Exchange approved the initial listing application on TIB of UNICOCELL BIOMED Co., Ltd. on January 15, 2024. Then it needs ratification by the Board of Directors of the Taiwan Stock Exchange.

For further inquiries, please contact Ms. Chiu at 1343@twse.com.tw.